CD8A and neoplasm: After the in vivo administration of DNX-2401, the infiltration degree of CD3+ lymphocytes and CD8+ lymphocytes in DIPG increased significantly and the DIPG murine cells were killed, leading to a significant increase in the survival of tumor-bearing animals [54].